Loading
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (3 ops.)
Latest filing published 09 Oct 2026 for CStone Pharmaceuticals - B.
Filing timeline
BuySaleLi Wei
Insider track record
Disclosed buys
15
Disclosed sells
3
Signal history
Closed purchases
Market purchases
15
Positive at T+90
50%
Median T+90
-8.4%
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +19.8%Entry HK$4.83 · Close at T+90 HK$5.78
- +7.9%Entry HK$4.67 · Close 21 Oct 2026 HK$5.04
- -9.5%Entry HK$1.99 · Close at T+365 HK$1.80
- +11.9%Entry HK$6.29 · Close at T+365 HK$7.04
- -57.9%Entry HK$0.28 · Close at T+365 HK$0.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Li Wei: trading record in brief
Li Wei appears in 40 filings spread over five companies listed on the Hong Kong stock exchange, all with the title Director: CStone Pharmaceuticals (18), Capital Finance Holdings Ltd. (6), VSTECS Holdings Ltd. (3), BFB Health Ltd. (3) and Shoucheng Holdings Ltd. (3). Publications run from July 12, 2018 to October 9, 2026.
The record leans toward buying: 15 purchases, 10 of them priced at EUR 5.7 million in total with a median of EUR 279,214, against 3 sales worth EUR 363,967. The largest purchase, EUR 2,188,178 on July 4, 2025, concerns New Hope Service Holdings Ltd.; next come two purchases at BFB Health, EUR 1,075,440 on August 9, 2023 and EUR 1,061,285 on July 21, 2023. The largest sale is EUR 233,773, on May 2, 2025, at Capital Finance Holdings.
Activity picks up: 1 to 5 filings a year through 2024, then 10 in 2025 and 10 in 2026. For the 10 purchases with a 90-day result, the stored median is -8.4% and half are positive (stored past results, not a forecast). The publication delay is 4 days at the median.
Companies and markets linked to Li Wei
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
20,833 sharesShareXHKGHKEX:DA20261008E00565
41,666 sharesShareXHKGHKEX:DA20260909E00519
20,833 sharesShareXHKGHKEX:DA20260707E00453
62,499 sharesShareXHKGHKEX:DA20260701E00098
100,000 shares@ HK$4.440.0052% mcap39.6% of flowShareXHKGHKEX:DA20260612E00329
Canonical exit: 9 Sept 2026 (T+90)
50,000 shares@ HK$4.400.0026% mcap19.7% of flowShareXHKGHKEX:DA20260611E00338
Canonical exit: 8 Sept 2026 (T+90)
499,996 sharesShareXHKGHKEX:DA20260512E00248
20,833 sharesShareXHKGHKEX:DA20260306E00332
20,833 sharesShareXHKGHKEX:DA20260205E00083
20,833 sharesShareXHKGHKEX:DA20260107E00470
20,833 sharesShareXHKGHKEX:DA20251205E00232
20,833 sharesShareXHKGHKEX:DA20251106E00469
20,833 sharesShareXHKGHKEX:DA20251009E00446
20,833 sharesShareXHKGHKEX:DA20250908E00377
41,666 sharesShareXHKGHKEX:DA20250807E00347
80,000 sharesShareXHKGHKEX:DA20250731E00067
Canonical exit: 21 Sept 2025 (T+90)
20,833 sharesShareXHKGHKEX:DA20250714E00336
12,252,000 shares@ HK$1.65100.0% of flowShareXHKGHKEX:DA20250708E00597
Canonical exit: 2 Oct 2025 (T+90)
270,833 sharesShareXHKGHKEX:DA20250701E00150
3,532,640 shares@ HK$0.579928.3% of flowShareXHKGHKEX:DA20250506E00241
4,000 shares@ HK$17.78100.0% of flowShareXHKGHKEX:DA20241212E00425
Canonical exit: 6 Mar 2025 (T+90)
2,000,000 sharesShareXHKGHKEX:DA20240403E00073
Canonical exit: 26 Jun 2024 (T+90)
544,800,000 sharesShareXHKGHKEX:DA20240311E00431
30,778,750 shares@ HK$0.3049.7% of flowShareXHKGHKEX:DA20230918E00327
Canonical exit: 19 Oct 2023 (T+90)
30,778,750 shares@ HK$0.3050.3% of flowShareXHKGHKEX:DA20230810E00362
Canonical exit: 7 Nov 2023 (T+90)
25 of 40 declarations
